If it’s been a while since you’ve seen your doctor, it may be time to schedule a visit to catch up on preventive health screenings or discuss any health concerns and chronic medical conditions. During the 15 months since people began quarantining, many have avoided leaving their homes except when necessary, including not going to…  read on >  read on >

A newly approved lung cancer drug shows promise in improving survival in patients whose tumors carry a common and tough-to-treat genetic mutation, researchers say. Sotorasib — brand name Lumakras — was approved May 28 by the U.S. Food and Drug Administration as a targeted therapy for non-small cell lung cancer patients with tumors that express…  read on >  read on >

U.S. teens are getting their COVID shots — how does that change their daily lives? Besides letting teens resume many of their normal activities, U.S. authorization of the Pfizer COVID-19 vaccine for people as young as 12 is crucial to slowing the spread of the coronavirus, one expert says. “We know that teenagers can not…  read on >  read on >

A twice-daily pill can dramatically reduce the risk of breast cancer recurrence in women who are genetically prone to the disease, researchers report. The pill — olaparib (Lynparza) — works by blocking a natural enzyme called PARP that normally fixes DNA damage in healthy cells, but in these women actually promotes the growth of cancerous…  read on >  read on >